2024
Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy
Lipska K, Oladele C, Zawack K, Gulanski B, Mutalik P, Reaven P, Lynch J, Lee K, Shih M, Lee J, Aslan M. Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy. Diabetes Technology & Therapeutics 2024, 26: 908-917. PMID: 39177775, DOI: 10.1089/dia.2024.0152.Peer-Reviewed Original ResearchVeterans with diabetesAssociation of raceCross-sectional analysis of dataU.S. Veterans Health AdministrationNational sample of veteransNational sampleInsulin therapyVeterans Health AdministrationSystem-level factorsSample of veteransNon-Hispanic patientsSelf-reported raceContinuous glucose monitoringCross-sectional analysisContinuous glucose monitoring useRate of prescriptionMultivariate mixed-effects modelAfrican American patientsLatino patientsHealth AdministrationAlaska NativesType 2 diabetesPercentage of patientsSignificant disparitiesMixed-effects models
2005
Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ, Gulanski B, Rosenheck R. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. The Journal Of Clinical Psychiatry 2005, 66: 1463-7. PMID: 16420085, DOI: 10.4088/jcp.v66n1117.Peer-Reviewed Original ResearchConceptsAtypical antipsychoticsFPG levelsElevated FPGUndiagnosed hyperglycemiaUrban Veterans Affairs Medical CenterVeterans Affairs Medical CenterNormal FPG levelsPercentage of patientsBody mass indexPlasma glucose testRace/ethnicityFPG resultsAntipsychotic prescriptionsMore patientsMass indexFPG groupMedical CenterGlucose testAntipsychoticsGlucose metabolismPatientsComorbid diagnosesHyperglycemiaGlucose resultsSignificant differences